SEC Form 4 · accession 0001213307-26-000005
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anthony Welters
Director
Period of report
Aug 26, 2026
Accepted (ET)
Aug 27, 2026 · 6:44 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 26, 2026 | M | 7,718 | $60.67 | A | 20,612 | D | |
| Common StockF2 | Aug 26, 2026 | S | 3,118 | $148.3106 | D | 17,494 | D | |
| Common StockF3 | Aug 26, 2026 | S | 4,600 | $148.824 | D | 12,894 | D | |
| Common Stock | Aug 26, 2026 | M | 10,282 | $61.35 | A | 23,176 | D | |
| Common StockF4 | Aug 26, 2026 | S | 3,402 | $148.2353 | D | 19,774 | D | |
| Common StockF5 | Aug 26, 2026 | S | 6,880 | $148.8227 | D | 12,894 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy)F6 | $60.67 | Aug 26, 2026 | M | 7,718 | D | — | Oct 22, 2030 | Common Stock | 7,718 | 0 | D |
| Non-qualified Stock Option (Right to Buy)F7 | $61.35 | Aug 26, 2026 | M | 10,282 | D | — | May 5, 2032 | Common Stock | 10,282 | 5,569 | D |
Explanation of responses
- F1The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026.
- F2Sale prices for the transactions reported range from $147.58 to $148.5799. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
- F3Sale prices for the transactions reported range from $148.58 to $149.5799. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
- F4Sale prices for the transactions reported range from $147.57 to $148.5699. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
- F5Sale prices for the transactions reported range from $148.57 to $149.5699. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
- F6100% of the shares subject to the stock option vested immediately upon the grant date of October 22, 2020.
- F725% of the shares subject to the option vested on each three-month anniversary measured from October 22, 2020 such that 100% of the shares subject to the option were fully vested and exercisable on October 22, 2021.